Intracavernous injection therapy for male erectile dysfunction.

Abstract

Intracavernosal injection therapy has consistently produced erections in 60% to 70% of patients in whom it is tried. About 70% of patients enter long-term therapy and there is a dropout rate of 20% to 50% within the first year. The most effective current regimen is a mixture of papaverine-phentolamine and prostaglandin E1, that also seems to have a relatively low incidence of priapism and fibrous nodule formation. Patient education is vitally important to the success of a program. Patient satisfaction rates are high.

• Authors: B Fallon
• Journal: The Urologic clinics of North America (Urol Clin North Am) Vol. 22 Issue 4 Pg. 833-45 (Nov 1995) ISSN: 0094-0143 [Print] United States
• PMID: 7483132 (Publication Type: Journal Article, Review)

Topics

• Drug Therapy, Combination
• Erectile Dysfunction (drug therapy, physiopathology)
• Humans
• Injections
• Male
• Patient Education as Topic
• Penile Erection (drug effects, physiology)
• Penis
• Self Care
• Treatment Outcome